Advicenne appoints Philippe Boucheron as Chairman of its Board of Directors

April 21, 2022

Paris, 21 April 2022 – 6.00 pm CEST – Advicenne (Euronext Growth Paris ALDVI -FR0013296746), a pharmaceutical company specializing in the development and commercialization of innovative treatments for those suffering from rare renal diseases, today announces the appointment of Philippe BOUCHERON as Chairman of the Board of Directors following the next Annual General Meeting to be held on June 9, 2022. This appointment follows David Horn SOLOMON’s decision not to seek the renewal of his term as director, entailing therefore the termination of his duties as Chairman of the Board of Directors from that same date.